Literature DB >> 31746958

Cannabidiol Products Are Everywhere, but Should People Be Using Them?

Rita Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31746958     DOI： 10.1001/jama.2019.17361

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and Attitudes.

Authors:  Jan M Schilling; Chloe G Hughes; Mark S Wallace; Michelle Sexton; Miroslav Backonja; Tobias Moeller-Bertram
Journal:  J Pain Res       Date:  2021-05-05       Impact factor: 3.133

2.  Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.

Authors:  David Hammond; Samantha Goodman
Journal:  Cannabis Cannabinoid Res       Date:  2020-10-29

Review 3.  Pain in sickle cell disease: current and potential translational therapies.

Authors:  Varun Sagi; Aditya Mittal; Huy Tran; Kalpna Gupta
Journal:  Transl Res       Date:  2021-03-09       Impact factor: 10.171

Review 4.  A Balanced Approach for Cannabidiol Use in Chronic Pain.

Authors:  Donovan A Argueta; Christopher M Ventura; Stacy Kiven; Varun Sagi; Kalpna Gupta
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

5.  Update on the developmental consequences of cannabis use during pregnancy and lactation.

Authors:  Kimberly S Grant; Elizabeth Conover; Christina D Chambers
Journal:  Birth Defects Res       Date:  2020-08-07       Impact factor: 2.661
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.